Triple
T10214446
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | methotrexate |
E242406
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | antifolate |
C26870
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: antifolate Context triple: [methotrexate, instanceOf, antifolate]
-
A.
antimetabolite
chosen
An antimetabolite is a drug that mimics natural cellular metabolites to interfere with DNA or RNA synthesis, thereby inhibiting cell growth and division, commonly used in cancer and autoimmune disease treatment.
-
B.
fluoropyrimidine
Fluoropyrimidines are a class of antimetabolite chemotherapy drugs structurally related to pyrimidine that inhibit DNA and RNA synthesis, commonly used in the treatment of various solid tumors.
-
C.
defoliant
A defoliant is a chemical substance used to cause plants to shed their leaves, typically to aid in agricultural harvesting or military operations.
-
D.
antitoxin
An antitoxin is a substance, typically an antibody, that neutralizes specific toxins produced by microorganisms or other biological sources.
-
E.
antioxidant
An antioxidant is a substance that inhibits oxidation by neutralizing free radicals, thereby protecting cells and molecules from oxidative damage.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381ae26c48190985abd0e25ee5d04 |
completed | April 6, 2026, 9:49 a.m. |
Created at: April 6, 2026, 11:04 a.m.